Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results
- Resource Type
- Article
- Source
- In
Blood Advances 13 June 2023 7(11):2283-2286 - Subject
Clinical Trials and Observations Gene Therapy - Language
- ISSN
- 2473-9529